Anavex Life Sciences Corp (AVXL)

[rocalinda]

--TWST: What drug candidates are the farthest along in the pipeline? Where are they and when could they potentially be commercialized?

Dr. Missling: The most of advanced compound in our pipeline is ANAVEX 2-73, which is now in a Phase 2a clinical trial in 32 mild-to-moderate Alzheimer’s patients. The next most advanced compounds are ANAVEX 3-71 and ANAVEX 1-41, which are both at the pre-IND stage. The next stage of clinical trials is in preparation for ANAVEX 2-73: a larger Phase 2/3 study as well as another Phase 2 in an orphan indication, and it could be Rett syndrome.

TWST: Is this for Alzheimer's?

Dr. Missling: We will conduct the Phase 2/3 for Alzheimer’s.